Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 312-48-1
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of edrophonium during breastfeeding. However, because of its short half-life and quaternary ammonium structure, it is unlikely to be excreted into breastmilk or orally absorbed by the infant. Administering the drug just after breastfeeding and waiting 2 to 3 hours before breastfeeding again should avoid any adverse reactions in the infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Edrophonium
CAS Registry Number
312-48-1
Drug Class
- Breast Feeding
- Lactation
- Cholinesterase Inhibitors
- Diagnostic Agents
- Parasympathomimetics
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Methscopolamine Bromide.[Drugs and Lactation Database (...]Review Methscopolamine Bromide.. Drugs and Lactation Database (LactMed®). 2006
- Review Amisulpride.[Drugs and Lactation Database (...]Review Amisulpride.. Drugs and Lactation Database (LactMed®). 2006
- Diverse inhibitory actions of quaternary ammonium cholinesterase inhibitors on Torpedo nicotinic ACh receptors transplanted to Xenopus oocytes.[Br J Pharmacol. 2007]Diverse inhibitory actions of quaternary ammonium cholinesterase inhibitors on Torpedo nicotinic ACh receptors transplanted to Xenopus oocytes.Olivera-Bravo S, Ivorra I, Morales A. Br J Pharmacol. 2007 Aug; 151(8):1280-92. Epub 2007 Jun 18.
- Review Iopamidol.[Drugs and Lactation Database (...]Review Iopamidol.. Drugs and Lactation Database (LactMed®). 2006
- Review Colistimethate.[Drugs and Lactation Database (...]Review Colistimethate.. Drugs and Lactation Database (LactMed®). 2006
- Edrophonium - Drugs and Lactation Database (LactMed®)Edrophonium - Drugs and Lactation Database (LactMed®)
- Abemaciclib - Drugs and Lactation Database (LactMed®)Abemaciclib - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...